University of Vermont Medical Center
Burlington, Vermont, 05401, United States
Location status: Recruiting
NCT Number: NCT06280300
This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Burlington, Vermont, 05401, United States
Location status: Recruiting
This is a cohort study of patient with newly diagnosed brain metastases assigned to standard of care (SOC) or intensive multi-disciplinary care (IMDC). Care for all patients with brain metastases involves complex medical decision making and requires input for multiple stakeholders, including medical oncology, neurosurgery, radiation oncology, and neuro-oncology. Palliative care should be an essential component of the care team for all patients with brain metastases by the very nature of this advanced malignancy. At the University of Vermont, our current process for diagnosis and management of patients with brain metastases relies heavily on the physician and team who make the initial diagnosis to consult others as they see appropriate. This process may look different for different patients. We rationalize that a systematic approach with intensive multidisciplinary care (IMDC) will benefit patients with brain metastases by providing consistent access to multi-disciplinary discussion.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Health services intervention
Time frame: 6-12 months
Symptom burden based on patient reporting on Brain Mets Symptom Inventory
Time frame: 6-12 months
Number of % of patients able to complete protocol-specified activities
Time frame: 6-12 months
Concordance with physician predication of prognosis
Time frame: 6-12 months
Survival outcomes for patients receiving best supportive care
Time frame: 6-12 months
90 day and 1 year survival
Contact information is provided by the study sponsor or research team.
University of Vermont Medical Center
Other
Intensive Multi-Disciplinary Care Initiative for Patients With Newly Diagnosed Brain Metastases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06047379
Adenocarcinoma, Astrocytoma
Beverly Hills, California, United States
View Trial DetailsNCT06620380
Brain Diseases, Brain Metastases
Basel, Switzerland
View Trial DetailsNCT05419076
Brain Diseases, Brain Metastases
Basking Ridge, New Jersey, United States
View Trial DetailsNCT04343157
Brain Diseases, Brain Metastases, Adult
San Diego, California, United States
View Trial Details